{"id":24422,"date":"2024-11-26T14:52:49","date_gmt":"2024-11-26T17:52:49","guid":{"rendered":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/"},"modified":"2024-11-26T14:52:49","modified_gmt":"2024-11-26T17:52:49","slug":"viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes","status":"publish","type":"post","link":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/","title":{"rendered":"Viromed Medical AG: Plasma Frio como Antibi\u00f3tico Digital para os Pulm\u00f5es"},"content":{"rendered":"<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA Viromed Medical AG (s\u00edmbolo de cota\u00e7\u00e3o em bolsa: VMED; ISIN: DE000A3MQR65; &#8220;Viromed&#8221;) est\u00e1 impulsionando a pesquisa sobre plasma frio para prevenir pneumonia associada&agrave;ventila\u00e7\u00e3o mec\u00e2nica (VAP). Sob a dire\u00e7\u00e3o cient\u00edfica da excelente especialista Prof. Dra. Hortense Slevogt, cientista da BREATH na Escola M\u00e9dica de Hannover, o projeto inovador est\u00e1 pesquisando a seguran\u00e7a e efic\u00e1cia do plasma frio para matar bact\u00e9rias no trato respirat\u00f3rio para aprova\u00e7\u00e3o como terapia.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO an\u00fancio oficial da rede de pesquisa BREATH a este respeito foi publicado em 22 de novembro de 2024.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA renomada rede de especialistas BREATH (Biomedical Research in End-stage and Obstructive Lung Disease Hannover) \u00e9 um dos cinco locais do Centro Alem\u00e3o de Pesquisa Pulmonar (DZL) e re\u00fane de modo exclusivo a experi\u00eancia reconhecida internacionalmente em medicina respirat\u00f3ria translacional. A rede de pesquisa consiste em quatro grandes parceiros: Hannover Medical School, Leibniz Universit\u00e4t Hannover, Fraunhofer ITEM e CAPNETZ FOUNDATION.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA VAP \u00e9 uma complica\u00e7\u00e3o comum e s\u00e9ria em pacientes ventilados de modo mec\u00e2nico e invasivo durante pelo menos 48 horas. Estudos mostram que a VAP afeta 23-36% dos pacientes ventilados mecanicamente associada&agrave;ventila\u00e7\u00e3o prolongada, interna\u00e7\u00f5es prolongadas em UTI e hospital, bem como uma taxa de mortalidade estimada de 10-13%. Somente na Alemanha, cerca de 486.000 pacientes necessitaram de ventila\u00e7\u00e3o mec\u00e2nica em UTIs em 2023, que destacam a necessidade de medidas de preven\u00e7\u00e3o de VAP.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Uwe Perbandt, Diretor Executivo da Viromed Medical AG, explicou:<\/b> &#8220;Mesmo no passado, as pessoas n\u00e3o morriam de ferimentos com frequ\u00eancia, mas das infec\u00e7\u00f5es que se seguiam. Hoje, estamos caminhando para um cen\u00e1rio semelhante. Devido&agrave;crescente resist\u00eancia dos germes, muitas pessoas n\u00e3o podem mais ser ajudadas. Uma infec\u00e7\u00e3o \u00e9 sin\u00f4nimo de morte. Al\u00e9m disto, os antibi\u00f3ticos no corpo humano \u00e0s vezes levam dias para chegar&agrave;fonte da doen\u00e7a. N\u00e3o temos estes problemas com plasma frio. Ele pode chegar ao local da infec\u00e7\u00e3o em poucos minutos e destruir pat\u00f3genos, incluindo aqueles que j\u00e1 s\u00e3o resistentes a antibi\u00f3ticos, com a mesma rapidez. A vantagem mais importante \u00e9 que o plasma frio destr\u00f3i os germes fisicamente. E n\u00e3o pode haver resist\u00eancia a isto. Logo, se a efic\u00e1cia e a seguran\u00e7a do plasma frio continuarem sendo confirmadas no curso do estudo, o que acredito firmemente que far\u00e3o, temos aqui, na verdade, um &#8220;antibi\u00f3tico digital&#8221; que nos levar\u00e1 a dar um grande passo adiante na luta contra muitas doen\u00e7as. Deste modo, podemos salvar dezenas ou at\u00e9 centenas de milhares de vidas. Em minha opini\u00e3o, este ativo pode aumentar significativamente o valor da AG. Desde que a BREATH publicou a not\u00edcia na sexta-feira, j\u00e1 recebemos in\u00fameras consultas internacionais.&#8221;<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>A Prof. Dra. Hortense Slevogt, da Cl\u00ednica de Pneumologia e Infectologia, MHH, disse: <\/b>\u201cA pneumonia associada&agrave;ventila\u00e7\u00e3o mec\u00e2nica n\u00e3o s\u00f3 tem uma alta taxa de mortalidade, mas tamb\u00e9m coloca um fardo significativo no sistema de sa\u00fade devido ao aumento do uso de antibi\u00f3ticos, estadias mais longas dos pacientes e custos mais altos do tratamento. A crescente resist\u00eancia antibi\u00f3tica dos pat\u00f3genos torna necess\u00e1rias novas abordagens n\u00e3o antibi\u00f3ticas com urg\u00eancia. Se os resultados preliminares positivos de nosso estudo forem confirmados, o plasma frio pode revolucionar o tratamento de pacientes ventilados.&#8221;<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><b>Sobre a Viromed Medical AG:<\/b><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA Viromed Medical AG \u00e9 especializada em desenvolver, fabricar e distribuir produtos m\u00e9dicos. O neg\u00f3cio operacional da empresa, cotada em bolsa de valores desde outubro de 2022, tem foco em distribuir tecnologia inovadora de plasma frio para aplica\u00e7\u00f5es m\u00e9dicas atrav\u00e9s de sua subsidi\u00e1ria integral Viromed Medical GmbH. A Viromed pode contar com uma extensa base de clientes na regi\u00e3o DACH (Alemanha &#8211; \u00c1ustria &#8211; Su\u00ed\u00e7a), incluindo empresas DAX como Volkswagen e Lufthansa, autoridades e minist\u00e9rios estaduais e federais, bem como 1.100 hospitais, 7.000 farm\u00e1cias e 11.000 consult\u00f3rios m\u00e9dicos.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nFoi comprovado cientificamente que o plasma atmosf\u00e9rico frio (CAP) inativa v\u00edrus, fungos e bact\u00e9rias nocivos e tem o potencial de revolucionar m\u00e9todos de tratamento convencionais em uma ampla variedade de \u00e1reas. A Viromed Medical AG est\u00e1 fazendo um importante trabalho pioneiro neste campo. O CAP claramente superior j\u00e1 vem sendo utilizado para tratar ferimentos de dif\u00edcil cura. A Viromed est\u00e1 atualmente conduzindo ensaios cl\u00ednicos para uso em medicina pulmonar. A Viromed Medical AG vem buscando a meta de avan\u00e7ar ainda mais com o uso do CAP na medicina nos pr\u00f3ximos anos e aproveitar o potencial de crescimento correspondente.<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nIdioma:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nIngl\u00eas<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nEmpresa:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nViromed Medical AG<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nFlensburger Stra\u00dfe 18<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n25421 Pinneberg<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nAlemanha<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nTel.:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n+49 4101 809960<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nE-mail:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\"><a href=\"mailto:kontakt@viromed-medical.de\" rel=\"follow\" shape=\"rect\" target=\"_blank\">kontakt@viromed-medical.de<\/a><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nInternet:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\"><a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.viromed-medical-ag.de%2F&amp;esheet=54158284&amp;newsitemid=20241126307355&amp;lan=pt-BR&amp;anchor=https%3A%2F%2Fwww.viromed-medical-ag.de%2F&amp;index=1&amp;md5=591ab57ac2b66eaf84424eed61001f88\" rel=\"follow\" shape=\"rect\" target=\"_blank\">https:\/\/www.viromed-medical-ag.de\/<\/a><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nISIN:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nDE000A3MQR65<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nWKN:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nA3MQR6<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nCota\u00e7\u00e3o em bolsa:<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nMercado n\u00e3o oficial regulamentado em Berlim, D\u00fcsseldorf (Prim\u00e4rmarkt), Frankfurt (Basic Board) e Hamburgo<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO texto no idioma original deste an\u00fancio \u00e9 a vers\u00e3o oficial autorizada. As tradu\u00e7\u00f5es s\u00e3o fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que \u00e9 a \u00fanica vers\u00e3o do texto que tem efeito legal.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241126307355r1&amp;sid=brdno&amp;distro=ftp\"><span class=\"bwct31415\"><\/span><\/p>\n<p id=\"mmgallerylink\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><span id=\"mmgallerylink-phrase\">Ver a vers\u00e3o original em businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20241126307355\/pt\/\" rel=\"follow\" target=\"_blank\">https:\/\/www.businesswire.com\/news\/home\/20241126307355\/pt\/<\/a><\/span><\/p>\n<p><b>Contato:<\/b><\/p>\n<p>\nViromed Medical AG\n<\/p>\n<p>Uwe Perbandt\n<\/p>\n<p>Diretor Executivo\n<\/p>\n<p>E-mail: <a href=\"mailto:kontakt@viromed-medical.de\" rel=\"follow\" shape=\"rect\">kontakt@viromed-medical.de<br \/>\n<\/a><\/p>\n<p><a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.viromed-medical-ag.de&amp;esheet=54158284&amp;newsitemid=20241126307355&amp;lan=pt-BR&amp;anchor=www.viromed-medical-ag.de&amp;index=2&amp;md5=23524fbfd97cc43f0507cf3ba571c974\" rel=\"follow\" shape=\"rect\">www.viromed-medical-ag.de<\/a><\/p>\n<p><strong>Fonte: <\/strong><a href='http:\/\/www.businesswire.com\/portal\/site\/home\/' target='_blank'>BUSINESS WIRE<\/a><img src='https:\/\/api.dino.com.br\/v2\/news\/tr\/310864?partnerId=3197' alt=\"\" style=\"border:0px;width:1px;height:1px;\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Viromed Medical AG (s\u00edmbolo de cota\u00e7\u00e3o em bolsa: VMED; ISIN: DE000A3MQR65; &#8220;Viromed&#8221;) est\u00e1 impulsionando a pesquisa sobre plasma frio para prevenir pneumonia associada&agrave;ventila\u00e7\u00e3o mec\u00e2nica (VAP). Sob a dire\u00e7\u00e3o cient\u00edfica da excelente especialista Prof. Dra. Hortense Slevogt, cientista da BREATH na Escola M\u00e9dica de Hannover, o projeto inovador est\u00e1 pesquisando a seguran\u00e7a e efic\u00e1cia do [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-24422","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Viromed Medical AG: Plasma Frio como Antibi\u00f3tico Digital para os Pulm\u00f5es - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Viromed Medical AG: Plasma Frio como Antibi\u00f3tico Digital para os Pulm\u00f5es - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"og:description\" content=\"A Viromed Medical AG (s\u00edmbolo de cota\u00e7\u00e3o em bolsa: VMED; ISIN: DE000A3MQR65; &#8220;Viromed&#8221;) est\u00e1 impulsionando a pesquisa sobre plasma frio para prevenir pneumonia associada&agrave;ventila\u00e7\u00e3o mec\u00e2nica (VAP). Sob a dire\u00e7\u00e3o cient\u00edfica da excelente especialista Prof. Dra. Hortense Slevogt, cientista da BREATH na Escola M\u00e9dica de Hannover, o projeto inovador est\u00e1 pesquisando a seguran\u00e7a e efic\u00e1cia do [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/\" \/>\n<meta property=\"og:site_name\" content=\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-26T17:52:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241126307355r1&amp;sid=brdno&amp;distro=ftp\" \/>\n<meta name=\"author\" content=\"DINO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"DINO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\\\/\"},\"author\":{\"name\":\"DINO\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"headline\":\"Viromed Medical AG: Plasma Frio como Antibi\u00f3tico Digital para os Pulm\u00f5es\",\"datePublished\":\"2024-11-26T17:52:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\\\/\"},\"wordCount\":920,\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20241126307355r1&amp;sid=brdno&amp;distro=ftp\",\"articleSection\":[\"Not\u00edcias Corporativas\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\\\/\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\\\/\",\"name\":\"Viromed Medical AG: Plasma Frio como Antibi\u00f3tico Digital para os Pulm\u00f5es - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20241126307355r1&amp;sid=brdno&amp;distro=ftp\",\"datePublished\":\"2024-11-26T17:52:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20241126307355r1&amp;sid=brdno&amp;distro=ftp\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20241126307355r1&amp;sid=brdno&amp;distro=ftp\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Viromed Medical AG: Plasma Frio como Antibi\u00f3tico Digital para os Pulm\u00f5es\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\",\"name\":\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"description\":\"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\",\"name\":\"DINO\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"caption\":\"DINO\"},\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/author\\\/dino\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Viromed Medical AG: Plasma Frio como Antibi\u00f3tico Digital para os Pulm\u00f5es - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/","og_locale":"pt_BR","og_type":"article","og_title":"Viromed Medical AG: Plasma Frio como Antibi\u00f3tico Digital para os Pulm\u00f5es - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","og_description":"A Viromed Medical AG (s\u00edmbolo de cota\u00e7\u00e3o em bolsa: VMED; ISIN: DE000A3MQR65; &#8220;Viromed&#8221;) est\u00e1 impulsionando a pesquisa sobre plasma frio para prevenir pneumonia associada&agrave;ventila\u00e7\u00e3o mec\u00e2nica (VAP). Sob a dire\u00e7\u00e3o cient\u00edfica da excelente especialista Prof. Dra. Hortense Slevogt, cientista da BREATH na Escola M\u00e9dica de Hannover, o projeto inovador est\u00e1 pesquisando a seguran\u00e7a e efic\u00e1cia do [&hellip;]","og_url":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/","og_site_name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","article_published_time":"2024-11-26T17:52:49+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241126307355r1&amp;sid=brdno&amp;distro=ftp","type":"","width":"","height":""}],"author":"DINO","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"DINO","Est. tempo de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/#article","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/"},"author":{"name":"DINO","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"headline":"Viromed Medical AG: Plasma Frio como Antibi\u00f3tico Digital para os Pulm\u00f5es","datePublished":"2024-11-26T17:52:49+00:00","mainEntityOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/"},"wordCount":920,"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241126307355r1&amp;sid=brdno&amp;distro=ftp","articleSection":["Not\u00edcias Corporativas"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/","url":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/","name":"Viromed Medical AG: Plasma Frio como Antibi\u00f3tico Digital para os Pulm\u00f5es - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/#primaryimage"},"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241126307355r1&amp;sid=brdno&amp;distro=ftp","datePublished":"2024-11-26T17:52:49+00:00","author":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"breadcrumb":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241126307355r1&amp;sid=brdno&amp;distro=ftp","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20241126307355r1&amp;sid=brdno&amp;distro=ftp"},{"@type":"BreadcrumbList","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/viromed-medical-ag-plasma-frio-como-antibiotico-digital-para-os-pulmoes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ocanal.com\/noticias\/corporativas\/"},{"@type":"ListItem","position":2,"name":"Viromed Medical AG: Plasma Frio como Antibi\u00f3tico Digital para os Pulm\u00f5es"}]},{"@type":"WebSite","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website","url":"https:\/\/ocanal.com\/noticias\/corporativas\/","name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","description":"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ocanal.com\/noticias\/corporativas\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff","name":"DINO","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","caption":"DINO"},"url":"https:\/\/ocanal.com\/noticias\/corporativas\/author\/dino\/"}]}},"_links":{"self":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/24422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/comments?post=24422"}],"version-history":[{"count":0,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/24422\/revisions"}],"wp:attachment":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/media?parent=24422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/categories?post=24422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/tags?post=24422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}